Related Experiment Video
Updated: Jul 15, 2026
12:08
Improving IV Insulin Administration in a Community Hospital
Published on: June 11, 2012
Diabetes: the latest trends in glycemic control
John M Giurini1, Emily A Cook, Jeremy J Cook
1Harvard Medical School, Division of Podiatric Surgery, Department of Surgery, Beth Israel Deaconess Medical Center, Boston, MA 02215, USA.
Clinics in Podiatric Medicine and Surgery
|April 14, 2007
Summary
Managing blood sugar in hospitalized patients, especially those undergoing surgery, is crucial. This review explores current strategies and emerging treatments for optimal glycemic control in acute care settings.
Area of Science:
- Endocrinology
- Metabolic Disorders
- Clinical Medicine
Background:
- Diabetes mellitus is a growing global health concern.
- Inadequate glycemic control has severe consequences.
- Recent evidence highlights benefits of glycemic control in acute settings.
Purpose of the Study:
- To discuss glycemic control strategies in hospitals.
- To focus on perioperative glycemic management.
- To review emerging treatments and protocols.
Main Methods:
- Literature review of studies on glycemic control.
- Analysis of consensus and emerging guidelines.
- Consideration of specific protocols like insulin pumps and infusions.
Main Results:
- Lack of consensus on optimal hospital glycemic control.
- Growing evidence for acute setting benefits.
- Emerging therapies and protocols require consideration.
Conclusions:
- Effective glycemic control is vital, particularly perioperatively.
- Further research and consensus are needed for hospital protocols.
- Novel therapeutic approaches offer new management possibilities.
Related Concept Videos
01:15Diabetes: Management and Pharmacotherapy
The therapy for diabetes aims to alleviate hyperglycemia-related symptoms, prevent acute metabolic decompensation, and reduce chronic end-organ complications. Glycemic control is evaluated through short-term (self-monitoring, continuous glucose monitoring) and long-term (A1c, fructosamine) metrics, enabling near real-time tracking of blood glucose levels and reflecting glycemic control over specific time frames.
Insulin remains the cornerstone of treatment for most patients with type 1 and many...
Insulin remains the cornerstone of treatment for most patients with type 1 and many...
01:22Diabetes Mellitus: Type 2 and Gestational
Type 2 diabetes, characterized by insulin resistance, arises when the insulin receptors on cells lose responsiveness to insulin, diminishing the cell's capacity to take up glucose, resulting in elevated blood glucose levels. To receive a diagnosis of Type 2 diabetes, a series of blood glucose tests are necessary to assess whether the blood glucose falls within normal parameters. If the result is out of the normal range, a patient may be diagnosed as prediabetic or diabetic, depending on the...
01:22Diabetes Mellitus: Overview and Type I Subtype
Diabetes mellitus is a chronic metabolic disorder characterized by high blood glucose levels due to inadequate insulin production, insulin resistance, or both. The condition affects millions worldwide and can significantly impact their health and quality of life.
Type 1 diabetes is an autoimmune disease in which the immune system mistakenly attacks and destroys the insulin-producing beta cells in the pancreas. As a result, the body is unable to produce sufficient insulin, and individuals with...
Type 1 diabetes is an autoimmune disease in which the immune system mistakenly attacks and destroys the insulin-producing beta cells in the pancreas. As a result, the body is unable to produce sufficient insulin, and individuals with...
01:29Hyperglycemia
Hyperglycemia is an abnormally high blood glucose level. It is diagnosed by fasting glucose ≥126 mg/dL, 2-hour oral glucose tolerance test (or OGTT) ≥200 mg/dL, random glucose ≥200 mg/dL with symptoms, or HbA1c ≥6.5%. However, HbA1c results may be unreliable in certain conditions, such as anemia or hemoglobinopathies, and the diagnosis should be confirmed unless classic symptoms are present. Postprandial hyperglycemia is typically considered significant when glucose levels exceed 180 mg/dL two...
01:26Diabetes Mellitus: Introduction
Diabetes mellitus consists of chronic metabolic disorders characterized by persistent hyperglycemia. This elevated blood glucose results from defects in insulin secretion, impaired insulin action, or both. Insulin, produced by pancreatic β-cells, is essential for maintaining glucose homeostasis by facilitating cellular glucose uptake for energy or storage. Disruptions in insulin production or function lead to glucose accumulation in the bloodstream, causing the clinical features and long-term...
01:26Hypoglycemia
Hypoglycemia is a blood glucose level below 70 mg/dL. It commonly occurs in individuals using insulin or insulin-secreting drugs, but may also arise in non-diabetic conditions. People with type 1 diabetes are at the highest risk because they depend on exogenous insulin. People with type 2 diabetes are also at risk, especially when treated with insulin or medications such as sulfonylureas, which increase insulin release regardless of blood glucose levels. It develops when insulin levels exceed...